Clinical Trial Update: Dosing and Tolerability of Deoxycholic Acid vs. Polidocanol in the Treatment of Neurofibromatosis Type 1 Cutaneous Neurofibromas [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating dosing and tolerability of deoxycholic acid versus polidocanol for treating cutaneous neurofibromas in neurofibromatosis type 1; the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurofibromatosis Type

Drugs mentioned

• Deoxycholic acid (Deoxycholic acid)
• polidocanol (polidocanol)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Neurofibromatosis 1 | Phase 1 | Status: COMPLETED